SEC Form 4 · accession 0000899243-18-000596
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas O Daniel
Director
Period of report
Jan 3, 2018
Accepted (ET)
Jan 5, 2018 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 3, 2018 | A | 8,687 | $5.18 | A | 19,452 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2018 on quarterly basis in arrears.